Neuphoria Therapeutics (B1N0) Revenue

2 Followers

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had a revenue of 1.17M in the quarter ending Jun 30, 2026, with Infinity%. This bring the company's revenue in the last twelve months to 1.17M, Decreased 111.21%. In the fiscal year ending Jun 30, 2026, Neuphoria Therapeutics had annual revenue of 1.17M with -92.50% growth.

Revenue (ttm)

1.17M

Revenue Growth

―

P/S Ratio

14.83

Revenue/Employee

€1,174,165

Employees

Market Cap

€17.41M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2026	1.17M	-14.48M	-92.50%
Jun 30, 2025	15.65M	―	+∞%
Jun 30, 2024	―	―	―
Jun 30, 2023	―	-383.16K	-100.00%
Jun 30, 2022	383.16K	-544.39K	-58.69%
Jun 30, 2021	927.54K	895.48K	+2,792.97%
Jun 30, 2020	32.06K	-7.36M	-99.57%
Jun 30, 2019	7.40M	-4.55M	-38.08%
Jun 30, 2018	11.94M	-15.20M	-56.00%
Jun 30, 2017	27.15M	―	―